


















![]()
Fractyl Health, Inc. (GUTS) Q1 2026 Earnings Call May 12, 2026 4:30 PM EDT
Company Participants
Brian Luque - Head of Investor Relations & Corporate Development
Harith Rajagopalan - Co-Founder, CEO & Director
Lara Weber - CFO & Treasurer
Conference Call Participants
Angela Qian - Canaccord Genuity Corp., Research Division
Michael DiFiore - Evercore ISI Institutional Equities, Research Division
Chi Meng Fong
Michael Ulz - Morgan Stanley, Research Division
Jeffrey Cohen - Ladenburg Thalmann & Co. Inc., Research Division
Presentation
Operator
Good afternoon, and welcome to Fractyl Health First Quarter 2026 Financial Results and Business Update Call. [Operator Instructions].
I'll now turn the call over to Brian Luque, Head of Investor Relations and Corporate Development at Fractyl. Brian, you may now begin.
Brian Luque
Head of Investor Relations & Corporate Development
Thank you. This afternoon, we issued a press release that outlines the topics we plan to discuss today. This release is available at www.fractyl.com under the Investors tab.
Joining us on the call today are Dr. Harith Rajagopalan, Chief Executive Officer; and Lara Smith Weber, Chief Financial Officer.
During this call, we make forward-looking statements, which involve risks and uncertainties that may cause our actual results to differ materially from those expressed or implied by forward-looking statements. A discussion of these risks and uncertainties is included in our filings with the SEC from time to time, including the section titled Risk Factors in our annual report on Form 10-K for the year ended December 31, 2025, and our quarterly report on Form 10-Q filed today, which I encourage you to review.
Any forward-looking statements on the call are subject to substantial risks and uncertainties, speak only as of the call's original date, and we undertake no obligation to update or revise any of the statements, even if subsequent events cause our views to change.
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。